Oppenheimer reiterates Outperform rating, $55 target for Amrize
Oppenheimer maintained an Outperform rating on Amrize and kept its $55.00 price target, implying 44.0% upside versus the Sep 17 close of $38.19.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.